Minovia Therapeutics Ltd.

This early-stage study tests a new treatment called MNV-201 for people with low-risk myelodysplastic syndrome (MDS), a bone marrow disorder that causes low blood counts. The therapy uses the patient's own blood stem cells enriched with mitochondria from donated placentas to try t…

This study collects blood and skin samples from 100 people with primary mitochondrial diseases and healthy volunteers aged 3 to 85. Researchers will use these samples to understand how different mitochondrial mutations affect cell function and to identify potential biomarkers. Th…